Heading a day late to #ASCO2023 for the best possible reason. My daughter is graduating high school tomorrow. I did not think I’d live long enough to see her first day of school, and for many years, wouldn’t allow myself the luxury of daydreaming about this moment.

Amelia Mario Macis Jeff Kahn GRASP Hank Greely Conquer Cancer, the ASCO Foundation Dear Dr. Researcher, PhD de-bi, co Dave deBronkart (((E. Glen Weyl/衛谷倫))) ⿻ 🇺🇸/🇩🇪/🇹🇼 Jeff Bargmann Sappho Gilbert University of Pittsburgh, Katz Graduate School @PittPlusMe Pitt Center for Bioethics & Health Law Pitt Medical Alumni Association Pitt Med Magazine Johns Hopkins Medicine ASBH Christine Hodgdon ASCO

Grateful for the opportunity to spread some awareness of what rare cancer patients face and steps taken to change rare cancer research in this podcast. It's been a LONG STRANGE TRIP! m.youtube.com/watch?v=2h4YnZ…

Our company emerged from stealth yesterday! You can read about our efforts here - Precede Biosciences Emerges from Stealth to Dramatically Impact Precision Medicine with a First-in-Class Liquid Biopsy Platform globenewswire.com/news-release/2…

‼️Today Dec 4 is your last chance to vote for Toni Choueiri, MD if you haven't already! 🩺👩🏽‍🔬Knowing him from afar then as his mentee I can assure you he will do what is best for ALL patients, providers and researchers Vote here: asco.org/election UroToday.com OncoAlert

Congratulations to ⁦Aditya Bardia, MD⁩ - An amazing #breastcancer researcher!! Internationally renowned oncologist to lead breast cancer program and translational research integration at ⁦UCLA Health⁩ !! uclahealth.org/news/internati…

ASCO Election News. Congratulations to Toni Choueiri, MD on election to ASCO board of directors. Will be an important new voice in many regards! 👏👏👏 ASCO

Join Precede at #AACR24 from April 5-10 in San Diego to check out the latest scientific data for our comprehensive epigenomic #LiquidBiopsy platform that informs on actionable drug targets, pathways, and mechanisms of resistance all from 1mL of plasma. View details:

Come check out our work in section 40 poster #4 at #AACR2024 Precede Biosciences

x.com/i/article/1778…

Come join us poster side at ASCO 2024 - Dear Dr. Researcher, PhD Precede Biosciences oncodaily.com/blog/72223.html #ASCO2024 #Cancer #HER2 #LiquidBiopsy #PrecisionMedicine #OncoDaily #Oncology

#ESMO24 opens with an anecdote on Angiosarcoma thanks to the great work of Serena Nik-Zainal. She identified a UV signature through WGS of this patient’s tumor, he was subsequently treated with Pembro and is alive and well 6 years later.

#ESMO2024 highlight! Maryam Lustberg MD, MPH, FASCO GRASP

Very excited to see this in print! Such promising outcomes for immune cold #sarcomas with Botensilimab Plus Balstilimab ascopubs.org/doi/10.1200/JC… Agenus CU Cancer Center

Had such a great conversation with Scott Okuno! Thanks for letting me share my career story! CU Cancer Center

DAY 2 JUST AHEAD: Richard Lifton from Rockefeller University, Tuuli Lappalainen from NY Genome Center, Richard Gibbs from From the Labs at Baylor College of Medicine, Dr. Krystal Tsosie, PhD, MPH from Arizona State University & Dear Dr. Researcher, PhD from the Broad Institute lead a spectacular day at the 2025 @AGBT General Meeting. #AGBTGM

New review article led by Amy Wisdom, MD, PhD of @harvardradonc | Clinician's primer for soft tissue sarcomas: Nuances of histologic subtypes acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert Chandrajit Raut Candace Haddox, MD Jason L. Hornick, M.D., Ph.D. Dear Dr. Researcher, PhD

Review article led by Amy Wisdom, MD, PhD of @harvardradonc | Clinician's primer for soft tissue sarcomas: Nuances of histologic subtypes acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert Chandrajit Raut Candace Haddox, MD Jason L. Hornick, M.D., Ph.D. Dear Dr. Researcher, PhD

In 2022, Janice Cowden , Dear Dr. Researcher, PhD, & I sat together to hear the much anticipated DESTINY-Breast 04 trial results. As cancer survivors, when we see data, we see the patients behind the data, we ARE the patients behind the data, & we’re grateful to still be here! #ASCO25